Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Microrna-340 Inhibits the Migration, Invasion, and Metastasis of Breast Cancer Cells by Targeting Wnt Pathway Publisher Pubmed



Mohammadiyeganeh S1, 2 ; Paryan M3 ; Arefian E4 ; Vasei M5 ; Ghanbarian H1, 2 ; Mahdian R6 ; Karimipoor M6 ; Soleimani M7, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Department of Research and Development, Production and Research Complex, Pasteur Institute of Iran, Tehran, Iran
  4. 4. Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran
  5. 5. Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, P.O. Box: 1316943551, Tehran, Iran
  7. 7. Department of Hematology, School of Medical Science, Tarbiat Modares University, Jalal Ale Ahmad Highway, Tehran, Iran
  8. 8. Department of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center, Tehran, Iran

Source: Tumor Biology Published:2016


Abstract

MicroRNAs (miRNAs) play a key role in tumor metastasis based on their capacity to regulate the expression of tumor-related genes. Over-expression of key genes such as c-MYC and CTNNB1 (encoding β-catenin) in Wnt/β-catenin-dependent and ROCK1 in Wnt/β-catenin-independent signaling pathways (Rho/Rho-associated kinase (ROCK) signaling pathway) has already been identified as the hallmarks of many tumors, and their role in breast cancer has also been investigated and confirmed. miR-340 characterization as an onco-suppressor miRNA has been previously reported. However, the mechanism by which it inhibits metastasis has not been completely elucidated. Quantitative real-time PCR (qPCR), Western blot, and luciferase assays were used to confirm the effect of miR-340 on the 3′-untranslated region (UTR) of the target genes. Lentiviral particles containing miR-340 were also used to evaluate the effect of miR-340 restoration on cell proliferation, migration, and invasion in vitro in the invasive MDA-MB-231 cell line. By applying bioinformatic approaches for the prediction of miRNAs targeting 3′-UTRs of CTNNB1, c-MYC, and ROCK1, we found out that miR-340 could dramatically down-regulate metastasis by targeting Wnt signaling in breast cancer cells. In the current study, analyzing miR-340 by reverse transcription quantitative PCR (RT-qPCR) in MDA-MB-231 showed that it was remarkably down-regulated in the metastatic breast cancer cell line. We found that restoration of miR-340 in the invasive breast cancer cell line, MDA-MB-231, suppresses the expression of the target genes’ messenger RNA (mRNA) and protein and, as a result, inhibits tumor cell invasion and metastasis. Our findings highlight the ability of bioinformatic approaches to find miRNAs targeting specific genes. By bioinformatic analysis, we confirmed the important role of miR-340 as a pivotal regulator of breast cancer metastasis in targeting previously validated (ROCK1) and potentially novel genes, i.e., (CTNNB1 and c-MYC). © 2016, International Society of Oncology and BioMarkers (ISOBM).